NET PROFIT (x1000 DKK)
EMPLOYEES
Sixera Pharma AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
14
|
11
|
15 |
| Earnings before taxes |
-4,797
|
-6,182
|
-7,547 |
| EBITDA |
-4,797
|
-6,171
|
-7,532 |
| Total assets |
4,811
|
4,964
|
12,512 |
| Current assets |
4,475
|
4,630
|
12,149 |
| Current liabilities |
1,327
|
1,402
|
1,909 |
| Equity capital |
3,148
|
3,228
|
10,239 |
| - share capital |
64
|
59
|
65 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
65.4%
|
65.0%
|
81.8% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-99.4%
|
-124.3%
|
-60.2% |
| Current ratio |
337.2%
|
330.2%
|
636.4% |
| Return on equity (ROE) |
-152.4%
|
-191.5%
|
-73.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.